Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Journal of General Internal Medicine|November 15, 2022
Electronic Advisories Increase Naloxone Prescribing Across Health Care SettingsErica Heiman, Sothivin Lanh, Tim P Moran, et al.
Archives of Physical Medicine and Rehabilitation|August 31, 2020
Regional Variations in Rehabilitation Outcomes of Adult Patients With Traumatic Brain Injury: A Uniform Data System for Medical Rehabilitation InvestigationTolu O Oyesanya, Tim P Moran, Tamara R Espinoza, et al.
Biological Psychology|August 24, 2014
Mindset induction effects on cognitive control: a neurobehavioral investigationHans S Schroder, Tim P Moran, M Brent Donnellan, et al.
Leukemia & Lymphoma|July 29, 2008
The biology and therapeutic potential of natural regulatory T-cells in the bone marrow transplant settingJames M Coghill, Michael J Carlson, Tim P Moran, et al.
Cognitive, Affective & Behavioral Neuroscience|July 17, 2012
When the rules are reversed: action-monitoring consequences of reversing stimulus-response mappingsHans S Schroder, Tim P Moran, Jason S Moser, et al.
Basic & Clinical Pharmacology & Toxicology|February 1, 2021
Intentional suspected suicide exposures by poisoning among adolescents from 2009 to 2018 reported to the Georgia Poison Center and compared nationallyBritni Overall, Stephanie L Hon, Alison Jones, et al.
Cognitive, Affective & Behavioral Neuroscience|June 26, 2013
The relationship between depressive symptoms and error monitoring during response switchingHans S Schroder, Tim P Moran, Zachary P Infantolino, et al.
Journal of the American College of Emergency Physicians Open|October 27, 2023
Hydrofluoric acid ingestions: Retrospective evaluations from cases reported to the National Poison Data System 2007-2017Zachary Illg, Joseph Carpenter, Tim P Moran, et al.
Advanced Emergency Nursing Journal|July 30, 2019
Advanced Practice Provider Burnout in a Large Urban Medical CenterMeredith P Ashooh, Katherine Barnette, Tim P Moran, et al.
Clinical Toxicology (Philadelphia, Pa.)|June 13, 2025
Droperidol is associated with reduced length of stay in the treatment of cannabinoid hyperemesis syndromeGeoffrey S Kelly, Gavin Meeks, Bradley McCoul, et al.
Pageof 7